Eden Research's Sean Smith joins Proactive to talk about its first-half trading, which was in line with expectations with revenues up 33% at £1mln.

Product sales were £1mln, up 54% from the year earlier adn he said he is encouraged by the potential as we continue to rebound from the pandemic.

Bio-pesticides, in particular, are growing very rapidly, he adds, though the drought in southern Europe is presenting some challenges.

Pantheon Resources PLC (AIM:PANR, OTC:PTHRF) CEO Jay Cheatham and Technical Director Bob Rosenthal joined Proactive's Stephen Gunnion with the latest on the company's Alkaid-2 well in Alaska, with target depth now reached including 5,300ft of horizontal drilling.

Alkaid-2 is Pantheon’s first horizontal well on the Alaska North Slope and one of the most keenly anticipated development holes in the region for years.

Cheatham telling Proactive that the company is using unconventional production techniques, applying this technology to the conventional sandstone reservoirs encountered across the entire project area.

"In the vertical well, which was the pilot hole ... we found much better reservoir than what we saw in the Alkaid 1," Rosenthal added.

Irwin Natural president Adam Berk joined Proactive's Stephen Gunnion with details of an exclusive licensing deal with Entourage Health for its products in Canada.

Berk telling Proactive that Irwin Natural had been looking for the right partner to make a "big foray" into Canada.

Irwin will initially roll out about six SKUs (stock keeping units) to the Canadian market, with a slightly different offering to the US.

"It's the still well-known, trusted brand name of Irwin Naturals but the great thing is it's really powered by Entourage, the leader in the Canadian market," Berk said.

Benchmark Metals President Jim Grieg joined Steve Darling from Proactive to share news the company has releases a preliminary economic assessment for its Lawyers gold-silver project in British Columbia.

Greig telling Proactive the PEA calls for aa open-pit mining operation of Pretax net present value of 921-million and an internal rate of return of 30.5 per cent and 2.1-year payback.

Total resource production of 46.3 million tonnes over 12-year mine life and an Initial capital cost of 493-million dollars.

Grieg also says the company anticipates all necessary inputs for the Feasibility Study to be complete by Q2 2023, with delivery of the final FS report in Q4 2023.

PharmaDrug Inc (CSE:PHRX, OTCQB:LMLLF) CEO Daniel Cohen says the company has completed significant groundwork to support multi-kilogram production for use in the final drug production of PD-001, its patented, oral version of cepharanthine, to treat responsive cancers and COVID-19.

Cohen told Proactive that PharmaDrug has engaged Genvion Corporation to complete stability testing and forced degradation studies in support of future investigational new drug (IND) filings to the US Food and Drug Administration (FDA).

He said the company will soon update the market on its psychedelic biotech research.

RIWI Corp. (TSX-V:RIWI) CEO Greg Wong takes Proactive through the company's patented technology that allows for the rapid capture and assessment of large samples of broad, truly randomized opinion and perceptions data on an ongoing basis, often completing data collection in less than two weeks.

Wong telling Proactive that RIWI's customers include international development organizations, the government and public sectors, and private sector customers across the financial services, healthcare and life sciences industries, amongst others.

"What our research shows and what our data shows is we are able to reach people in hard-to-reach places," Wong said. "We've done surveys with about 2 billion different responses in 229 different countries in over 35 languages."

BitNile Holdings (NYSE-A:NILE) CEO Todd Ault explains the investment holding company's strategy of acquiring undervalued businesses and disruptive technologies as it builds a portfolio of diversified assets.

Ault explained that the company's holdings include a data centre business, a real estate business including investments in hotels, and a significant stake in early clinical-stage biopharmaceutical company Alzamend Neuro, a company that Ault founded.

"On top of all that, we mine Bitcoin and we are very, very invested in Bitcoin," Ault added. "We have spent more than $150 million building out our mining operation in Dowagiac, Michigan. So we are an unusual small cap holding company."

BioLargo Inc (OTCQB:BLGO) CEO Dennis Calvert takes Proactive's Stephen Gunnion through the company's second-quarter results, which show a 185% year-over-year jump in revenue to $1.32 million on the back of strong contributions from its engineering and environmental divisions.

Calvert telling Proactive that the company's PFAS (per- and polyfluoroalkyl substances) business is a major opportunity, and BioLargo is at the forefront of real environmental impact, working with channel partners to solve some of today’s toughest environmental challenges.

Soligenix CEO Chris Schaber joined Steve Darling from Proactive to share news the company has been very busy over the last moths with some major accomplishments including an agreement from the FDA on an initial pediatric study plan for HyBryte for the treatment of CTCL.

Schaber also told Proactive the company announced it had signed a worldwide exclusive license to supply its ricin antigen to SERB Pharmaceuticals, for development of a novel therapeutic treatment against ricin toxin poisoning.

Bitcoin has crashed over 7% this morning, following a large bout of selling pressure between 07:30 and 11:30.

Over US$1,000 has so far been wiped off and is now trending below US$22,000.

Ethereum fared slightly better with a 6% drop to US$1,730, having been propped up by a decent early-week rally on the back of a concrete date set for the upcoming Merge.

Fan-engagement token Chiliz rounded the week with a US$1.2bn market valuation after encountering a 30% rally in the past seven days.

Meanwhile the Celsius short squeeze continues to keep the CEL token afloat, having gained close to 9% over the past week.

Shiba Inu and Dogecoin meme coins also performed well, however most blockchain networks maintained a bearish position.

Solana, Polkadot, Polygon and Avalanche saw double digit losses across the weekly period, while Cardano dropped 8%.

EOS was one of the few blockchains to encounter positive price action, albeit at only 1%.

Totals volumes across the decentralised finance (DeFi) space fell around 7% this week, with Ethereum’s largest decentralised exchange Uniswap being among the worst hit.